In the wake of expected industry-wide regulation of consumer genomic testing, two of the big four testing companies, Navigenics and Pathway Genomics, have pulled their direct-to-consumer offerings in the last few months. Now a doctor must order their tests.
23andMe and deCODEme still have consumer genomic tests available, covering 174 conditions for $429 and 49 conditions for $2,000, respectively (Figure 1). Sooner rather than later could be a good time to sign up for a genomic service, possibly using year-end HSA dollars.
Figure 1. Landscape of direct-to-consumer genomic testing services.
The potential industry-wide regulation is in regard to two issues, one is whether a physician must order the tests, and two, whether companies should be able to publish their interpretations of the results.
The DIYgenomics website lists two online petitions in support of rights to one's own genetic data:
Email me
Twitter
Subscribe to blog
MS Futures Group
Data Visualization Wiki
Economic Fallacies
